MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0000443
Xellence Laboratories Private Limited
Xellence Laboratories Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹54.07 Lakh
▼ 9% YoY
Net profit · FY 2024
₹88,479
Net margin 1.6%
EBITDA · FY 2024
₹3.07 Lakh
EBITDA margin 5.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20.5 Lakh
Secured borrowings
Company age
20 yrs
Est. 2006
Directors on board
3
As per MCA filings
About Xellence Laboratories Private Limited
Data last updated:
Xellence Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2006PTC144867. Its GSTIN is 07AAACX0429R1ZX (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Divakar Sharma and Vivek Gambhir.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop 2 6 Rashid Market Krishna Nagar, New Delhi, Delhi, India – 110051.
As per the financials filed for FY 2024, the company reported a revenue of ₹54.07 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹88,479 (net margin 1.6%) and EBITDA of ₹3.07 Lakh (EBITDA margin 5.7%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹20.5 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Xellence Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0000443). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2006PTC144867
Registration Number 144867
Incorporation Date 16 January 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0000443
Recognitions & Rankings of Xellence Laboratories
Contact details
Xellence Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop 2 6 Rashid Market Krishna Nagar, New Delhi, Delhi, India – 110051
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xellence Laboratories Private Limited, buy the company report.
Comprehensive company report
Xellence Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Xellence Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xellence Laboratories Private Limited, buy the company report.
Financials of Xellence Laboratories Private Limited
FY 2024 filings availableXellence Laboratories Private Limited reported revenue of ₹54.07 Lakh (down 9% YoY) for FY 2024.
Revenue · FY 2024
₹54.07 Lakh ▼ 9%
Net profit · FY 2024
₹88,479 margin 1.6%
EBITDA · FY 2024
₹3.07 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▼ 28%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 2%
5 years · compounded
▼ 9%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 9% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88,479 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xellence Laboratories Private Limited, buy the company report.
Board of directors of Xellence Laboratories Private Limited
Xellence Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divakar Sharma | Director | 16 Jan 2006 | 20 Years 9 Months | Current |
| Vivek Gambhir | Director | 16 Jan 2006 | 20 Years 9 Months | Current |
| Jitender Bansal Also directs: Ilex Biologicals Private Limited | Director | 16 Jan 2006 | 20 Years 9 Months | Current |
Peer comparison
Xellence Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Varada Multiservices Private Limited | ₹54.17 Lakh (FY 2023) | -24.0% | Delhi, India | |||
| Aone Pharma and Surgicals Private Limited | ₹54.14 Lakh (FY 2025) | 37.0% | Pune, Maharashtra, India | |||
| Sunbird Healthcare Private Limited | ₹54.09 Lakh (FY 2025) | -30.0% | Raipur, Chhattisgarh, India | |||
| Xellence Laboratories Private Limitedthis company | ₹54.07 Lakh (FY 2024) | ₹88,479 | 1.6% | -9.0% | New Delhi, Delhi, India | |
| Miles Healthcare Private Limited | ₹54.03 Lakh (FY 2025) | -17.0% | Ahmedabad, Gujarat, India | |||
| Sanivo Biotec Private Limited | ₹53.76 Lakh (FY 2024) | -3.0% | South 24 Parganas, West Bengal, India | |||
| Bioplus Healthcare Private Limited | ₹53.5 Lakh (FY 2025) | 140.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Xellence Laboratories Private Limited, buy the company report.
Auditor
Xellence Laboratories Private Limited is audited by P G N G & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P G N G & ASSOCIATES | FY 2021 | 032157N |
Shareholding
The shareholding of Xellence Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xellence Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Apr 2014 | 10502737 | The Nainital Bank Limited | ₹5.5 Lakh | Open | |
| 14 Dec 2012 | 10396727 | The Nainital Bank Limited | ₹15 Lakh | Open |
To see the full charge records of Xellence Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Xellence Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by M/S Ethix Healthcare | Disposed |
To see the full case history of Xellence Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xellence Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xellence Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACX0429R1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xellence Laboratories Private Limited, buy the company report.
Recent activity
Xellence Laboratories Private Limited has 4 board changes on record since 2006: 3 appointments and 1 cessation. The latest: Vishal Singh ceased to be Director on 01 Jan 2011.
AGM
Xellence Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Xellence Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with The Nainital Bank Limited amounted to Rs. 5.50 Lakh with Charge ID 10502737 was registered on 07 Apr 2014.
Charges
A charge with The Nainital Bank Limited of Rs. 15.00 Lakh registered on 14 Dec 2012 with Charge ID 10396727 was modified on 30 Dec 2013.
Charges
A charge with The Nainital Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 10396727 was registered on 14 Dec 2012.
Ceased
Vishal Singh ceased to be Director.
Appointed
Divakar Sharma was appointed as Director.
Appointed
Jitender Bansal was appointed as Director.
Appointed
Vivek Gambhir was appointed as Director.
Incorporation
16 Jan 2006
Xellence Laboratories Private Limited was registered on 16 Jan 2006 with Roc Delhi & aged 20 years 9 months as per MCA records.
Frequently asked questions
Xellence Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2006 (20+ years old) and is registered under CIN U24232DL2006PTC144867.
Xellence Laboratories has 3 current directors:
- Divakar Sharma - Director
- Vivek Gambhir - Director
- Jitender Bansal - Director
The latest financial statements of Xellence Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Xellence Laboratories is 07AAACX0429R1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Xellence Laboratories is U24232DL2006PTC144867. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xellence Laboratories has 1 court case on record: 1 filed against it.
Xellence Laboratories was incorporated on 16 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Xellence Laboratories by revenue are Varada Multiservices Private Limited, Aone Pharma and Surgicals Private Limited, Sunbird Healthcare Private Limited, Miles Healthcare Private Limited, Sanivo Biotec Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Vishal Singh ceased to be Director on 01 Jan 2011. Divakar Sharma was appointed as Director on 16 Jan 2006. Jitender Bansal was appointed as Director on 16 Jan 2006. Xellence Laboratories has 4 board changes on record in total.
Yes, Xellence Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0000443).
The registered office of Xellence Laboratories is at Shop 2 6 Rashid Market Krishna Nagar, New Delhi, Delhi, India – 110051.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages